FDA warns about Able drug recall
May 27, 2005
Able Laboratories Inc. recalled all of its generic drugs, according to the U.S. Food and Drug Administration, in a never before seen move. Earlier this year, the company also recalled three other medicines, and sought the returns of the rest of its products last week after an internal investigation found problems with its testing procedures.
In addition, the drug company withdrew seven drug applications that had been pending with the FDA. Included in Able’s generic drug versions is the attention-deficit disorder drug Ritalin and the painkiller Vicodin. Making nitroglycerin, lithium and generic Tylenol, the FDA has posted a complete listing of Able’s recalled drugs on its Web site for concerned consumers.
Two main reasons for Able’s drug recalls have been cited as underreporting of problems dating back to 2004 and improper manufacturing. Over 40 generic drugs were produced by the company, and now the once up-and-coming company finds itself in the midst of an unprecedented move, resulting in its’ CEO to resign.
Before patients make any medication changes, doctors should first be consulted.For more information on drug safety concerns, please contact us.
